Aralez Pharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
16,708.30
19,674.70
37,783.40
102,978.00
125,205.00
Depreciation, Depletion & Amortization
29.40
18.90
16.20
12,968.00
35,801.00
Other Funds
522.40
192.50
2,951.50
963.00
6,341.00
Funds from Operations
12,647.90
18,895.90
30,525.20
81,539.00
41,647.00
Changes in Working Capital
11,769.00
18,530.20
13,736.00
2,192.00
12,861.00
Net Operating Cash Flow
878.90
365.60
16,789.20
83,731.00
28,786.00
Capital Expenditures
1.70
7.30
240.10
4,881.00
1,822.00
Sale of Fixed Assets & Businesses
-
-
-
-
523.00
Purchase/Sale of Investments
18,838.00
-
2,479.40
-
-
Net Investing Cash Flow
18,836.30
7.30
2,239.30
222,768.00
1,514.00
Cash Dividends Paid - Total
53,685.50
-
-
-
-
Issuance/Reduction of Debt, Net
-
-
-
270,300.00
-
Net Financing Cash Flow
53,546.00
7,396.40
1,216.80
346,263.00
6,233.00
Net Change in Cash
35,588.60
7,754.70
15,766.70
40,127.00
36,051.00
Free Cash Flow
880.60
358.30
17,029.40
87,897.00
30,608.00
Deferred Taxes & Investment Tax Credit
-
-
-
3,952.00
1,066.00
Net Assets from Acquisitions
-
-
-
217,887.00
-
Change in Capital Stock
662.00
7,588.90
1,734.80
75,000.00
108.00
Exchange Rate Effect
-
-
-
363.00
482.00
Other Uses
-
-
-
-
215.00
About Aralez Pharmaceuticals
View Profile
